A Dark Vector Cognition product

Item 5. Other information

3K characters. Original on sec.gov · Markdown

Item 5. Other information

Rule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements

During the three months ended March 31, 2025, certain of our officers or directors adopted or terminated trading arrangements for the sale of shares of our common stock.

ActionDatePlansNumber of Securities to be SoldExpiration
Rule 10b5-1 1Non-Rule 10b5-1 2
Julius Genachowski, DirectorAdoptionMarch 13, 2025X-Up to 622 shares of Class A common stockThe earlier of (i) the date when all securities under the plan are sold and (ii) August 15, 2026
Linda Kirkpatrick, President, AmericasAdoptionMarch 14, 2025X-Up to 2,875 shares of Class A common stockThe earlier of (i) the date when all securities under the plan are sold and (ii) September 30, 2025
Timothy Murphy, Vice Chair and Former Chief Administrative Officer 3AdoptionFebruary 4, 2025X-Up to (i) 11,567 shares of Class A common stock underlying employee stock options and (ii) 6,572 shares of Class A common stockThe earlier of (i) the date when all securities under the plan are exercised and sold and (ii) December 31, 2025
Raj Seshadri, Chief Commercial Payments OfficerAdoptionMarch 14, 2025X-Up to 5,181 shares of Class A common stockThe earlier of (i) the date when all securities under the plan are sold and (ii) December 31, 2025
Craig Vosburg, Chief Services OfficerAdoptionMarch 6, 2025X-Up to (i) 28,284 shares of Class A common stock underlying employee stock options and (ii) 4,623 shares of Class A common stockThe earlier of (i) the date when all securities under the plan are exercised and sold and (ii) February 6, 2026

1Intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

2Not intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

3Mr. Murphy became Vice Chair effective May 1, 2025.

Other Information

Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012, we hereby incorporate by reference herein the disclosure contained in Exhibit 99.1 of this Report.

Previous: Item 1A. Risk factors · Next: Item 6. Exhibits